Many labs are growing mini-hearts now, but University at Albany researcher says it has managed to take the heart all the way through the stages of development.

The WHO’s 2025 report highlights global disparities in the detection of substandard and falsified medical products, ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

According to IBHE data, public universities across Illinois face more than $8.3 billion in deferred maintenance. This backlog ...

Verve received FDA IND clearance for VERVE-102 to treat HeFH, adding new trial sites in the United States. Read more about ...

The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market. ...